Logo for Contineum Therapeutics Inc

Contineum Therapeutics Investor Relations Material

Latest events

Logo for Contineum Therapeutics

Q2 2024

14 Aug, 2024
Logo for Contineum Therapeutics

Q1 2024

16 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Contineum Therapeutics Inc

Access all reports
Contineum Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel, oral small molecule therapies. The company focuses on treatments for neuroscience, inflammation, and immunology (NI&I) conditions that have significant unmet medical needs. Contineum is headquartered in San Diego, California, and its shares are listed on the NASDAQ.